Opioid-Induced Urinary Retention

Introduction to Opioid-Induced Urinary Retention

The American Society of Clinical Oncology notes that opioid-induced urinary retention occurs in approximately 25% of postoperative patients and is more common during the early course of treatment, with elderly patients facing higher risk due to benign prostatic hyperplasia and polypharmacy 1, 2
The mechanism involves opioid receptor activation in the bladder and sphincter, causing failure of bladder contraction and increased sphincter tone, according to the Journal of Clinical Oncology 1, 2

When urinary retention develops in a patient on methadone, the American Society of Clinical Oncology recommends ruling out other causes first, especially spinal cord compression, and reviewing all medications to modify the regimen if feasible 1, 2
Acute management of opioid-induced urinary retention involves catheterization for immediate relief, as suggested by the Journal of Clinical Oncology 1, 2
Pharmacologic interventions for opioid-induced urinary retention include tamsulosin (alpha-blocker), which has been reported beneficial, particularly in postoperative opioid use, according to the Journal of Clinical Oncology 1, 2
Peripheral opioid antagonists, such as methylnaltrexone or naldemedine, can reverse urinary retention by blocking peripheral opioid receptors in the bladder without affecting central analgesia, as noted by the Journal of Clinical Oncology 1
Low-dose naloxone infusion (0.25 mg/kg/h) may be considered for the management of opioid-induced urinary retention, according to the Journal of Clinical Oncology 1, 2
Opioid rotation to synthetic opioids like fentanyl may have lower rates of urinary retention, as suggested by the Journal of Clinical Oncology and the American Society of Clinical Oncology 1, 2, 3

The American Society of Clinical Oncology emphasizes that spinal cord compression must be excluded in cancer patients before attributing symptoms solely to opioids, as this is a critical diagnostic consideration that can be life-threatening if missed 1, 2

Elderly patients with compromised autonomic function are at substantially elevated risk of urinary retention due to morphine use, which can be exacerbated by neurogenic bladder from diabetic autonomic insufficiency 4
The American Geriatrics Society recommends considering the risk of urinary retention in elderly patients with pre-existing conditions, such as benign prostatic hyperplasia and polypharmacy with multiple anticholinergic medications, when initiating morphine therapy 4

The National Comprehensive Cancer Network recommends considering rotation to synthetic opioids like fentanyl, which have lower rates of urinary retention compared to morphine, as a strategy to prevent urinary retention in high-risk patients 5
Transdermal fentanyl has been shown to have lower rates of urinary retention compared to oral morphine regimens, according to a meta-analysis of randomized controlled trials 5